David Myerson
Overview
Explore the profile of David Myerson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDonald G, Sarmiento J, Rees-Lui G, Myerson D
J Viral Hepat
. 2019 Jul;
26(11):1344-1350.
PMID: 31315152
Mortality from cytomegalovirus disease after marrow transplantation can be reduced by treatment with antiviral drugs based on the detection of viremia and organ involvement. We examined autopsy liver specimens to...
2.
Myerson D, Parkin R
Virchows Arch
. 2018 Dec;
474(3):365-374.
PMID: 30539318
Reconstitution of hepatocytes by hematopoietic stem cells-a phenomenon which occurs in rodents under highly selective conditions-results from infrequent fusion between incoming myelomonocytes and host hepatocytes, with subsequent proliferation. Human hematopoietic...
3.
Hill J, Myerson D, Marty F
N Engl J Med
. 2018 Jun;
378(26):2544-5.
PMID: 29952184
No abstract available.
4.
Taraseviciute A, Tkachev V, Ponce R, Turtle C, Snyder J, Liggitt H, et al.
Cancer Discov
. 2018 Mar;
8(6):750-763.
PMID: 29563103
Chimeric antigen receptor (CAR) T-cell immunotherapy has revolutionized the treatment of refractory leukemias and lymphomas, but is associated with significant toxicities, namely cytokine release syndrome (CRS) and neurotoxicity. A major...
5.
Gust J, Hay K, Hanafi L, Li D, Myerson D, Gonzalez-Cuyar L, et al.
Cancer Discov
. 2017 Oct;
7(12):1404-1419.
PMID: 29025771
Lymphodepletion chemotherapy followed by infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells can be complicated by neurologic adverse events (AE) in patients with refractory B-cell malignancies. In 133 adults...
6.
Steinbach G, Hockenbery D, Huls G, Furlong T, Myerson D, Loeb K, et al.
PLoS One
. 2017 Aug;
12(8):e0183284.
PMID: 28817727
Trial Registration: ClinicalTrials.gov NCT00408681.
7.
Myerson D, Steinbach G, Gooley T, Shulman H
Biol Blood Marrow Transplant
. 2017 May;
23(9):1573-1579.
PMID: 28533059
The pathologic interpretation of gut biopsies in hematopoietic cell transplant recipients to assess graft-versus-host disease (GVHD) is well accepted and supplements clinical and endoscopic findings. However, the histologic activity grading...
8.
Seo S, Renaud C, Kuypers J, Chiu C, Huang M, Samayoa E, et al.
Blood
. 2015 Apr;
125(24):3789-97.
PMID: 25918347
Newer diagnostic methods may link more idiopathic pneumonia syndrome (IPS) cases to an infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell transplant (HCT) recipients with IPS diagnosed between...
9.
Shulman H, Cardona D, Greenson J, Hingorani S, Horn T, Huber E, et al.
Biol Blood Marrow Transplant
. 2015 Feb;
21(4):589-603.
PMID: 25639770
The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus...
10.
Hill J, Sedlak R, Zerr D, Huang M, Yeung C, Myerson D, et al.
Biol Blood Marrow Transplant
. 2014 Sep;
21(2):371-3.
PMID: 25255164
We identified 37 hematopoietic cell transplantation recipients with human herpesvirus 6 (HHV-6) central nervous system dysfunction and tested donor-recipient pairs for chromosomally integrated HHV-6 (ciHHV-6). One patient had ciHHV-6A with...